-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 10, Jiao Hong, director of the State Food and Drug Administration, investigated and inspected the quality and supply of new crown epidemic prevention and control drugs in Shijiazhuang City
, Hebei Province.
Jiao Hong stressed that it is necessary to always adhere to the people's first and life first, strengthen the supervision and management of the whole process of drug production and circulation, especially in the special period of epidemic prevention and control, we must pay close attention to the quality and safety supervision of all links, resolutely guard the bottom line of safety, effectively ensure the safety of the people's medication, and fully serve the overall situation
of epidemic prevention and control.
Yan Pengcheng, Vice Governor of Hebei Province, investigated
together.
, Hebei Province.
Jiao Hong stressed that it is necessary to always adhere to the people's first and life first, strengthen the supervision and management of the whole process of drug production and circulation, especially in the special period of epidemic prevention and control, we must pay close attention to the quality and safety supervision of all links, resolutely guard the bottom line of safety, effectively ensure the safety of the people's medication, and fully serve the overall situation
of epidemic prevention and control.
Yan Pengcheng, Vice Governor of Hebei Province, investigated
together.
In Hebei Jiuzhou Tong Pharmaceutical Co.
, Ltd.
, Jiao Hong and his entourage inspected the work of epidemic prevention and control drug supply guarantee, storage and transportation, and investigated the implementation of quality management standards for drug business and strengthening quality management
in circulation links 。 Jiao Hong pointed out that at present, China's epidemic prevention and control has entered a new stage, and the people have higher requirements for the quality safety and supply guarantee of new coronavirus infection treatment drugs.
Drug regulatory departments should take the special rectification of drug safety as the starting point, increase the intensity of supervision and inspection, strengthen all-round supervision online and offline, and effectively maintain the order
of the drug market.
, Ltd.
, Jiao Hong and his entourage inspected the work of epidemic prevention and control drug supply guarantee, storage and transportation, and investigated the implementation of quality management standards for drug business and strengthening quality management
in circulation links 。 Jiao Hong pointed out that at present, China's epidemic prevention and control has entered a new stage, and the people have higher requirements for the quality safety and supply guarantee of new coronavirus infection treatment drugs.
Drug regulatory departments should take the special rectification of drug safety as the starting point, increase the intensity of supervision and inspection, strengthen all-round supervision online and offline, and effectively maintain the order
of the drug market.
At CSPC Ouyi Pharmaceutical Co.
, Ltd.
, Jiao Hong and his entourage went to the drug production site and logistics center to carefully inquire about the expansion and supply of
symptomatic treatment drugs related to new coronavirus infection.
Jiao Hong said that the quality safety and stable supply of epidemic prevention and control drugs are related to the overall situation of epidemic prevention and control work, and pharmaceutical manufacturers, as the first responsible person for drug quality and safety, should consolidate the main responsibility for drug quality and safety, improve and effectively operate the quality management system, implement drug production quality management practices, and resolutely guard the bottom line
of drug quality and safety 。 Drug regulatory departments should carefully study and analyze the drug quality risks that may arise from the current growth of drug market demand, coordinate supervision and services, promote the expansion of production and capacity of enterprises in accordance with laws and regulations, support enterprise R&D innovation and ensure production and supply, continue to strengthen drug quality supervision, and ensure the overall situation of epidemic prevention and control work
.
, Ltd.
, Jiao Hong and his entourage went to the drug production site and logistics center to carefully inquire about the expansion and supply of
symptomatic treatment drugs related to new coronavirus infection.
Jiao Hong said that the quality safety and stable supply of epidemic prevention and control drugs are related to the overall situation of epidemic prevention and control work, and pharmaceutical manufacturers, as the first responsible person for drug quality and safety, should consolidate the main responsibility for drug quality and safety, improve and effectively operate the quality management system, implement drug production quality management practices, and resolutely guard the bottom line
of drug quality and safety 。 Drug regulatory departments should carefully study and analyze the drug quality risks that may arise from the current growth of drug market demand, coordinate supervision and services, promote the expansion of production and capacity of enterprises in accordance with laws and regulations, support enterprise R&D innovation and ensure production and supply, continue to strengthen drug quality supervision, and ensure the overall situation of epidemic prevention and control work
.
The main responsible comrades of the Drug Supervision Department of the State Food and Drug Administration, the Hebei Provincial Market Supervision Bureau and the Hebei Provincial Food and Drug Administration participated in the investigation
.
.
